XML 25 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 9 Months Ended 12 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Dec. 31, 2022
Dec. 31, 2022
Cash flows from operating activities        
Net (loss) / income $ (14,880,000)   $ 821,000  
Adjustments to reconcile net (loss) / income to net cash (used in) / provided by operating activities:        
Depreciation and amortization expense 1,004,000   873,000  
Stock-based compensation expense 1,626,000   2,482,000  
Deferred tax benefit (230,000)   (146,000)  
Accrued income from long-term investments (141,000)   (129,000)  
Provision for expected credit loss 1,074,000    
Gain on lease termination (13,000)    
Others (50,000)   (1,000)  
Change in fair value of forward purchase agreement put option liability 17,247,000    
Change in fair value of derivative warrant liabilities (852,000)    
Loss on issuance of shares against accounts payable 48,000    
Changes in operating assets and liabilities:        
Accounts receivable (6,070,000)   (2,630,000)  
Prepaid expenses and other current assets (623,000)   (505,000)  
Operating right-of-use assets (825,000)   (6,200,000)  
Other assets 416,000   (1,737,000)  
Accounts payable 451,000   (177,000)  
Accrued compensation and related benefits, current (22,000)   (1,397,000)  
Other current liabilities 29,000   4,174,000  
Operating lease liabilities 926,000   6,452,000  
Other liabilities 910,000   438,000  
Net cash provided by (used in) operating activities 25,000 $ 33,723 2,318,000 $ (446,617)
Cash flows from investing activities        
Acquisition of property and equipment (1,062,000)   (1,388,000)  
Issuance of loans to affiliates (1,730,000)   (1,041,000)  
Payments received for loans to affiliates 1,722,000   1,011,000  
Net cash provided by investing activities (1,070,000) 189,434,603 (1,418,000)
Cash flows from financing activities        
Net proceeds from short term borrowings 1,748,000   1,012,000  
Payment of promissory note liability (1,500,000)    
Payment of insurance financing liability (239,000)    
Proceeds from long-term debt 575,000   138,000  
Repayment of long-term debt (388,000)    
Payment of finance lease obligations (323,000)   (290,000)  
Payment of deferred transaction costs (2,055,000)   (434,000)  
Net changes in net shareholders’ investment (10,000)   18,000  
Proceeds from issuance of common stock and forward purchase agreement in connection with Business Combination, net 8,666,000    
Net cash used in financing activities 6,474,000 (189,508,040) 444,000 (8,461)
Effect of exchange rate changes on cash and cash equivalents (17,000)   (51,000)  
Net decrease in cash 5,412,000 (39,714) 1,293,000 (455,078)
Cash and cash equivalents at the beginning of the period 1,131,000 $ 1,644,000 351,000  
Cash and cash equivalents at the end of the period 6,543,000   1,644,000 $ 1,644,000
Supplemental cash flow disclosure:        
Cash paid for interest 253,000   171,000  
Cash paid for income taxes, net of refunds 1,057,000   789,000  
Supplemental disclosure of non-cash investing and financing activities:        
Unpaid deferred transaction costs included in accounts payable and other current liabilities 908,000   569,000  
Equipment acquired under finance lease obligations 313,000   82,000  
Property and equipment purchase included in accounts payable 81,000   9,000  
Settlement of accounts payable through issuance of Class A ordinary shares to vendors 855,000    
Assumption of net liabilities from Business Combination $ 38,994,000